Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease
about
Selective Phosphodiesterase Inhibitors for Psoriasis: Focus on ApremilastCan roflumilast, a phosphodiesterase-4 inhibitor, improve clinical outcomes in patients with moderate-to-severe chronic obstructive pulmonary disease? A meta-analysisPharmacological strategies to reduce exacerbation risk in COPD: a narrative reviewRebuttal from Dr Rho et al.Quantitative benefit-harm assessment for setting research priorities: the example of roflumilast for patients with COPDAnti-inflammatory effects of the novel inhaled phosphodiesterase type 4 inhibitor CHF6001 on virus-inducible cytokinesInhaled corticosteroids and the increased risk of pneumonia: what's new? A 2015 updated review.Role of Inflammation and Oxidative Stress in the Pathology of Ageing in COPD: Potential Therapeutic Interventions.Reduced COPD exacerbation risk correlates with improved FEV1: A meta-regression analysis.The Relationship between Airway Inflammation and Exacerbation in Chronic Obstructive Pulmonary Disease.Roflumilast, a phosphodiesterase-4 inhibitor, induces phagocytic activity in Greek COPD patientsRecommendations for the pharmacological treatment of COPD: questions and answers.Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease.A negative allosteric modulator of PDE4D enhances learning after traumatic brain injury.Pattern and Adherence to Maintenance Medication Use in Medicare Beneficiaries with Chronic Obstructive Pulmonary Disease: 2008-2013.Health status in patients with COPD treated with roflumilast: two large noninterventional real-life studies: DINO and DACOTA.
P2860
Q26781755-399D43F8-9DFA-4B69-8402-864FC84B75E3Q28070108-B21263C3-046E-465D-9CCA-64907C47F56EQ28070274-403601FC-1103-4D89-8F9C-7CD613296C51Q33572580-B2E477E4-AEE4-4C17-95AE-766783837A53Q35681671-06474E8F-5179-454D-8E4A-6D46A83B4EA5Q36648886-002F31E1-946F-472A-92A4-E4E0906840BAQ38740312-24C105BA-4B10-4B07-8D58-B4E6A655B635Q38953736-962EEDE2-8CE1-49B5-9C60-B897B88BA02EQ39292087-FEE3BFE8-A508-434F-8FBB-0C109FBA9B74Q40041766-FF2BDCCE-4E1E-4EE1-BCAA-E73DDA3FC3F3Q41837804-2D9420DB-4CE0-40BB-B0AD-6820A96E1943Q47272746-0EF0FF8B-7847-4CF9-9707-977E9A858E4CQ47551310-17D51CA2-7627-48A8-B289-B70A8E77ABE6Q47665411-7033C2F7-FE82-4B5A-8CC7-123505AF78F3Q52599392-C5E56DEE-88DF-48E3-9E61-89B933871A55Q55234651-3698C7BB-6D31-4EE5-B522-F6EA24E125B9
P2860
Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease
@ast
Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease
@en
Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease
@en-gb
Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease
@nl
type
label
Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease
@ast
Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease
@en
Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease
@en-gb
Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease
@nl
prefLabel
Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease
@ast
Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease
@en
Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease
@en-gb
Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease
@nl
P2860
P3181
P1476
Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease
@en
P2093
Bonnie Leung
Jimmy Chong
P2860
P3181
P356
10.1002/14651858.CD002309.PUB4
P577
2013-11-04T00:00:00Z